StockClub

BBBT

BBBTBlack Bird Biotech, Inc.$ --
Black Bird Biotech, Inc.

Black Bird Biotech, Inc.

BBBT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2023FY2023 Q3
Revenue
0M USD
YoY -84.7%
Operating Income
-0M USD
YoY +93.9%
Net Income
-0M USD
YoY +51.6%
EPS
-0$
YoY +87.5%

Revenue

$24,244
FY2021 Q4$104,458
$104,458
Q4
FY2022 Q1$13,802
$13,802
Q1
FY2022 Q2$44,745
$44,745
Q2
FY2022 Q3$70,484
$70,484
Q3
FY2022 Q4$82,563
$82,563
Q4
FY2023 Q1$7,385
$7,385
Q1
FY2023 Q2$20,307
$20,307
Q2
FY2023 Q3$24,244
$24,244
Q3
Actual
$-46,240 (-65.6%)

Net Income

$-779,377
FY2021 Q4$-1.8M
$-1.8M
Q4
FY2022 Q1$-670,359
$-670,359
Q1
FY2022 Q2$-1.2M
$-1.2M
Q2
FY2022 Q3$-1.5M
$-1.5M
Q3
FY2022 Q4$-1.7M
$-1.7M
Q4
FY2023 Q1$-451,195
$-451,195
Q1
FY2023 Q2$-648,150
$-648,150
Q2
FY2023 Q3$-779,377
$-779,377
Q3
Actual
+$684,904 (+46.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017
Actual:$0
FY2017
$0
FY2018
Actual:$0
FY2018
$0
FY2019
Actual:$17,771
FY2019
$17,771
FY2020
Actual:$57,604
FY2020
$57,604
FY2021
Actual:$104,458
FY2021
$104,458
FY2022
Actual:$82,563
FY2022
$82,563

Analyst Estimates

No forecast data